1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Apnimed reported second-quarter 2026 results that swung to net income of $125.9 million, compared with a net loss of $69.5 million a year earlier. The gain was driven by an $85.4 million gain on sale of an equity method investment and a $57.1 million gain on reversal of a deposit liability, while revenue fell to $12.1 million from $17.1 million and the operating loss widened to $11.7 million from $5.9 million. The results also cover the completed IPO, with gross proceeds of $220.8 million, and the FDA's acceptance of the NDA for AD109 (proposed name Oxnimbi) with a PDUFA date of February 28, 2027.
Net income of $125.9 million, or $3.91 per diluted share, versus a net loss of $69.5 million, or $14.61 per share, in Q2 2025
Revenue - related party was $12.1 million versus $17.1 million a year earlier; loss from operations was $11.7 million versus $5.9 million
G&A expenses rose to $12.7 million from $5.4 million, while R&D fell 38% to $9.9 million
Cash and cash equivalents were $172.8 million at June 30, 2026, before the IPO's $220.8 million in gross proceeds
Mission Produce reported fiscal third-quarter 2026 results for the quarter ended July 31, 2026. Revenue rose 26% to $450.0 million, but the company posted a net loss attributable to Mission Produce of $6.5 million, or $(0.08) per diluted share, including $25.4 million of pre-tax Calavo acquisition-related costs, compared with income of $14.7 million, or $0.21 per share, a year earlier. The company reaffirmed its second-half fiscal 2026 Adjusted EBITDA outlook of $84 million to $88 million and raised its estimated annualized Calavo synergy opportunity to more than $30 million.
Revenue $450.0 million, up 26%; avocado volume up 38% and per-unit prices down 9%
Net loss attributable to Mission Produce $6.5 million, or $(0.08) per diluted share, versus income of $14.7 million, or $0.21, a year earlier
Adjusted net income $15.0 million, or $0.18 per diluted share, versus $18.2 million, or $0.26, a year earlier
Second-half fiscal 2026 Adjusted EBITDA outlook of $84 million to $88 million reaffirmed; fourth-quarter Adjusted EBITDA expected at $52 million to $55 million
InnovAge reported fiscal 2026 revenue of $989.7 million, up about 15.9% from $853.7 million, and a net loss attributable to the company of $2.5 million, or $0.02 per share, versus $30.3 million, or $0.22 per share, a year earlier. The company also issued fiscal 2027 guidance calling for revenue of $1,050 million to $1,085 million and Adjusted EBITDA of $105 million to $115 million, but it accrued $52.4 million in litigation losses for the year, which weighs on shareholder results.
Fiscal 2026 Adjusted EBITDA was $94.6 million, up from $34.5 million in fiscal 2025; the margin was 9.6%.
Fourth-quarter net income attributable to InnovAge was $8.3 million, or $0.06 per share, compared with a loss of $0.8 million a year earlier.
Fiscal 2026 litigation costs and settlements totaled $57.0 million, including $52.4 million of accrued losses for potential resolutions or paid settlements.
Fiscal 2027 guidance: census of 8,625 to 8,850 participants, total revenues of $1,050 million to $1,085 million, and Adjusted EBITDA of $105 million to $115 million.
QNB Corp. sold $254.4 million in available-for-sale securities with a 1.59% weighted-average yield and unwound $162.0 million in notional pay-fixed swaps, reinvesting proceeds at an expected blended yield of about 5.45%. The company estimates a net pre-tax loss of about $26.2 million, to be included in its third-quarter 2026 results, and expects to recover that loss in under four years.
Sold $254.4 million in book value of AFS securities at a 1.59% weighted-average yield, about 46.8% of the securities portfolio
Unwound $162.0 million in notional pay-fixed swaps as part of the repositioning
Estimated net pre-tax loss of about $26.2 million, included in third-quarter 2026 financial results
Sales had no impact on shareholders' equity or book value per share as of the sale date
GameStop reported second-quarter results for the period ended August 1, 2026, with operating income of $160.2 million, up from $66.4 million a year earlier, and net income of $298.7 million, up from $168.6 million. Net sales fell to $790.2 million from $972.2 million, and the company raised its fiscal 2026 Adjusted EBITDA outlook to in excess of $650 million from over $600 million.
Operating income was $160.2 million, the highest second-quarter operating income in company history, compared with $66.4 million a year earlier.
Net sales were $790.2 million versus $972.2 million; the company cites the prior-year Nintendo Switch 2 launch, planned store closures and the France divestiture.
Net income of $298.7 million included a $166.3 million gain on a derivative asset and a $72.1 million unrealized gain on an equity investment in eBay.
Fiscal 2026 Adjusted EBITDA outlook raised to in excess of $650 million, up from the over $600 million outlook given on June 26, 2026.
Group 1 Automotive said it intends to sell $1.25 billion of senior unsecured notes in a private offering, split evenly between notes due 2032 and 2035, to help fund its pending purchase of dealership assets from Hennessy Automobile Companies. If that acquisition does not close by the outside date, the company must redeem the 2032 notes. The offering memorandum excerpts show revenue and net income for the six months ended June 30, 2026 below the prior-year period, and pro forma net leverage of 4.2 times, so the deal adds debt while results have declined.
$625.0 million of 2032 notes and $625.0 million of 2035 notes, subject to market conditions
Proceeds, with cash on hand, will fund the Hennessy Acquisition of 10 Atlanta-area dealerships, one collision center and related real estate
2032 notes must be redeemed at 100% of issue price plus accrued interest if the Hennessy deal is not completed by the later of January 6, 2027 or the extended outside date
Six months ended June 30, 2026: total revenues $10,792.2 million vs. $11,208.8 million; net income $233.5 million vs. $268.6 million
Rigetti's subsidiary signed an Other Transaction Agreement with the U.S. Department of Commerce on September 4, 2026, for up to $100 million in CHIPS Act funding for superconducting quantum computing research. As a condition of the award, Rigetti agreed to issue 7,739,938 shares of common stock to the Department at an implied price of $12.92 per share, which will dilute existing stockholders.
Award of up to $100 million, paid in tranches of $43.9 million, $29.9 million and $26.2 million if milestones are met
Agreement signed September 4, 2026; share issuance under a Securities Issuance Agreement dated September 8, 2026, at an implied $12.92 per share
Department may demand repayment of payments as a debt for material non-compliance, and may terminate the agreement
Shares were issued in a private transaction exempt from registration under Section 4(a)(2) of the Securities Act
United Natural Foods reported fourth-quarter fiscal 2026 net income of $35 million, compared with a net loss of $87 million a year earlier, while net sales fell 0.7% to $7.6 billion. The company also gave fiscal 2027 guidance and, on September 3, 2026, authorized a new share repurchase program of up to $200 million, which replaces the September 2022 program.
Q4 fiscal 2026 net income of $35 million ($0.57 diluted EPS) vs. a net loss of $87 million a year earlier; Adjusted EBITDA rose 48.3% to $172 million.
Full-year fiscal 2026 net sales fell 2.0% to $31.2 billion; net income was $84 million vs. a net loss of $118 million in fiscal 2025.
Fiscal 2027 guidance: net sales $31.2-$31.8 billion, net income $105-$145 million, Adjusted EPS $3.00-$3.50, Adjusted EBITDA $730-$780 million.
Board authorized up to $200 million in share repurchases on September 3, 2026; the program has no fixed expiration date.
On September 6, 2026, WaFd entered a merger agreement under which EverBank Financial Corp will merge into WaFd, with WaFd surviving and renamed EverBank Financial Corp. EverBank shareholders would receive WaFd shares, leaving EverBank holders with about 59.175% of the combined company and WaFd holders with about 40.825%, and the deal requires WaFd shareholder and regulatory approvals. WaFd expects approximately 29% EPS accretion in 2027, but its current shareholders would own a smaller share of the company.
Merger agreement dated September 6, 2026; EverBank shareholders approved it by written consent.
About 107.7 million WaFd shares estimated to be issued at closing; ownership split is fixed at 59.175% EverBank holders and 40.825% WaFd holders.
WaFd would pay a $101,060,629 cash termination fee in certain circumstances; either party may terminate if the merger is not completed by September 6, 2027.
Greg Seibly to serve as CEO and Brent Beardall as president; Robert Radway to be chairman; 13-member board. Closing expected in early 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.